Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New York Times

F.D.A. Names and Shames Drug Makers to Encourage Generic Competition - The New York Times

Opinion Why Competition Won't Bring Down Drug Prices - The New York Times

Pharma-Firms-Swap-Assets

GlaxoSmithKline Pharmaceuticals: GSK Pharma to invest Rs 1,000 crore in Karnataka plant - The Economic Times

Fed Up With Drug Companies, Hospitals Decide to Start Their Own - The New York Times

GlaxoSmithKline agrees to pay out millions in diabetes drug class action

Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New York Times, generic

GSK 2022: A newly focused biopharma company - PharmaLive

Glaxo, Pfizer joint venture creates world's largest supplier of over-the-counter drugs - Los Angeles Times

Take the Generic, Patients Are Told. Until They Are Not. - The New York Times

Take the Generic, Patients Are Told. Until They Are Not. - The New York Times

China Fines GlaxoSmithKline Nearly $500 Million in Bribery Case - The New York Times

GlaxoSmithKline accused of paying competitors to delay drug

Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New York Times, generic